Author

J. A. Mas-Rosario

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

M. E. Farkas· 3 shared E. M. Rizzo· 1 shared H.-H. Lin· 1 shared J. D. Medor· 1 shared J. Hardie· 1 shared J. M. Martinez-Montes· 1 shared M. I. Jeffway· 1 shared M. Nguyen· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. E. Farkas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 18, 2022

Macrophage-Based iNos Reporter Reveals Polarization and Reprogramming in the Context of Breast Cancer

J. A. Mas-Rosario, J. D. Medor, M. I. Jeffway…·M. E. Farkas

This paper develops a macrophage reporter system to study polarization and reprogramming in breast cancer models using iNos promoter activity.

DOI 10.1101/2022.08.18.504212

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivJul 1, 2021

Macrophage Circadian Rhythms are Differentially Affected Based on Stimuli

S. S. L. Don, J. A. Mas-Rosario, H.-H. Lin…·M. E. Farkas

This study examines how macrophage polarization and cancer cell-conditioned media affect circadian rhythms in macrophages and cancer cells, revealing distinct circadian characteristics based on phenotype.

DOI 10.1093/intbio/zyac007

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivMar 18, 2019

Macrophage Activation by a Substituted PyrimidoIndole Increases Anti-Cancer Activity

J. Hardie, J. A. Mas-Rosario, S. Ha…·M. E. Farkas

This paper reports a small molecule TLR agonist, PBI1, that activates macrophages to enhance anti-tumor activity, showing five-fold increased phagocytic efficiency compared to untreated macrophages.

DOI 10.1016/j.phrs.2019.104452

experimental assaycancer & tumor microenvironment

𝕏 PostBluesky